Artificial Intelligence–Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial
Künstliche Intelligenz-gestützte EKGs zur Identifikation von Vorhofflimmern und verbesserten Verordnung oraler Antikoagulanzien: pragmatische randomisierte klinische Studie
Journal of the American Heart Association · 15.07.2025 · 14 (14)
DOI: 10.1161/jaha.125.042106 ↗Auf einen Blick
In einer cluster-randomisierten Studie in 2 Krankenhäusern in Taiwan erhöhten AI-EKG-Alerts die Verordnung nicht-Vitamin-K-Antagonist-oraler Antikoagulanzien und die Vorhofflimmerdiagnose.
Fragestellung
Verbessern AI-EKG-Alerts die Vorhofflimmerdiagnose und die Verordnung nicht-Vitamin-K-Antagonist-oraler Antikoagulanzien durch Nichtkardiolog:innen?
Methode
Offene cluster-randomisierte kontrollierte Studie in 2 Krankenhäusern in Taiwan; Nichtkardiolog:innen wurden Interventions- oder Kontrollgruppe zugeteilt; Alerts bei AI-detektiertem Vorhofflimmern.
Ergebnisse
8857 und 8960 Patient:innen wurden in Interventions- und Kontrollgruppe behandelt. Die Verordnungsrate lag bei 23,3 % versus 12,0 %; HR 1,85 (95 %-KI 1,11–3,07). Die AF-Diagnose war ebenfalls häufiger: HR 1,40 (95 %-KI 1,03–1,90).
Schlussfolgerung der Autor:innen
Ein AI-EKG-Alert zur Identifikation von Vorhofflimmern förderte die Verordnung nicht-Vitamin-K-Antagonist-oraler Antikoagulanzien und verringerte Unterschiede in der AF-Versorgung zwischen Kardiolog:innen und Nichtkardiolog:innen.
Kernaussagen
- Verordnung: 23,3 % versus 12,0 %
- AF-Diagnose häufiger mit Alert: HR 1,40 (95 %-KI 1,03–1,90)
- Keine signifikanten Unterschiede bei weiteren klinischen Endpunkten
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Pragmatische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 15.07.2025. Verfasst von Wei-Ting Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan, R.O.C. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Artificial Intelligence, Electrocardiography. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is often underdiagnosed and undertreated by noncardiologists. This study evaluated whether artificial intelligence–enabled ECG (AI‐ECG) alerts could improve AF diagnosis and non–vitamin K antagonist oral anticoagulant prescriptions by noncardiologists.
Methods
In this open‐label, cluster randomized controlled trial (NCT05127460) at 2 hospitals in Taiwan, noncardiologists were randomized to an intervention group (AI‐ECG alerts) or control group (usual care). Alerts were sent to physicians when AI‐ECG identified AF in emergency or hospitalized patients at risk of stroke (CHA₂DS₂‐VASc ≥1 for men, ≥2 for women), excluding those with prior AF or oral anticoagulant use. Primary end points included a non–vitamin K antagonist oral anticoagulant prescription within 90 days after discharge, new AF diagnosis, echocardiogram arrangements, and cardiologist visits. Secondary end points were ischemic stroke, cardiovascular death, and all‐cause death.
Results
A total of 8857 and 8960 patients were treated by 120 and 113 noncardiologists in the intervention and control groups, respectively; 275 and 245 patients had AI‐detected AF. The non–vitamin K antagonist oral anticoagulant prescription rate was significantly higher in the intervention group (23.3% versus 12.0%; hazard ratio [HR], 1.85 [95% CI, 1.11–3.07]). The intervention group also had a higher rate of AF diagnosis (HR, 1.40 [95% CI, 1.03–1.90]). No significant differences were observed in echocardiogram arrangements, cardiologist visits, or the rates of ischemic stroke, cardiovascular death, and all‐cause death.
Conclusions
An AI‐ECG alert for AF identification promoted non–vitamin K antagonist oral anticoagulant prescriptions among noncardiologists, thus reducing the disparity in AF care quality between cardiologists and noncardiologists. Registration URL: https://clinicaltrials.gov/ ; Unique identifier: NCT05127460.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan, R.O.C.
- Medical Technology Education Center, School of Medicine National Defense Medical Center Taipei Taiwan, R.O.C.
- Department of Artificial Intelligence of Things Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan, R.O.C.
- School of Public Health National Defense Medical Center Taipei Taiwan, R.O.C.
- Department of Family and Community Medicine, Department of Internal Medicine Tri-Service General Hospital, National Defense Medical Center Taipei Taiwan, R.O.C.
- Graduate Institute of Life Sciences, National Defense Medical Center Taipei Taiwan, R.O.C.
ORCID-Profile: Wei-Ting Liu, Chin Lin, Chiao-Chin Lee, Chiao-Hsiang Chang, Wen-Hui Fang, Dung-Jang Tsai, Wen-Yu Lin, Yuan Hung, Kai-Chieh Chen, Chun-Ho Lee, Shih-Hua Lin, Chien-Sung Tsai, Chin-Sheng Lin
Zitieren
APA
Liu, W. T., Lin, C., Lee, C. C., Chang, C. H., Fang, W. H., Tsai, D. J., Lin, W. Y., Hung, Y., Chen, K. C., Lee, C. H., Tsai, T. N., Lin, W. S., Hung, Y. J., Lin, S. H., Tsai, C. S., & Lin, C. S. (2025). Artificial Intelligence–Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial. Journal of the American Heart Association, 14(14). https://doi.org/10.1161/jaha.125.042106
Vancouver
Liu WT, Lin C, Lee CC, Chang CH, Fang WH, Tsai DJ, et al. Artificial Intelligence–Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial. Journal of the American Heart Association. 2025;14(14). doi:10.1161/jaha.125.042106
BibTeX
@article{Liu2025,
author = {Liu, Wei-Ting and Lin, Chin and Lee, Chiao-Chin and Chang, Chiao-Hsiang and Fang, Wen-Hui and Tsai, Dung-Jang and Lin, Wen-Yu and Hung, Yuan and Chen, Kai-Chieh and Lee, Chun-Ho and Tsai, Tsung-Neng and Lin, Wei-Shiang and Hung, Yi-Jen and Lin, Shih-Hua and Tsai, Chien-Sung and Lin, Chin-Sheng},
title = {Artificial Intelligence–Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {14},
doi = {10.1161/jaha.125.042106}
}
EUVIMED